A big owner of Medline sold $60.4M of Medline shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Oct 5, 2026
Reporting period
Not applicable
Filed with the SEC
Oct 7, 2026
10% owner$1M+
Context
Classification
open market sale
Code S — open-market or private sale
Absolute commitment
~$60,421,328
Shares × reported transaction price
Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001193125-26-416053
Filed / recorded
Oct 7, 2026, 1:48 AM UTC
Added to OQRO
Oct 7, 2026, 2:15 AM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
Medline Inc.
Issuer CIK
2046386
Ticker
MDLN
Reporting person
GIC Private Ltd
Relationship
10% owner
Security
Class A Common Stock
Table
Non-derivative (Table I)
Transaction date
Oct 5, 2026
Transaction code
S
Shares / units
1,688,690
Price per share
$35.78
Acquired / disposed
Disposed (D)
Shares owned after
18,542,793
Ownership form
Direct
Amendment
No
Footnotes from the filing
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.59 to $36.23, inclusive. The reporting person undertakes to provide to Medline Inc., any security holder of Medline Inc., or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (4) to this Form 4.
Each Reporting Person disclaims beneficial ownership of the securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.